Improving Noninvasive Methods of Assessing Liver Fibrosis in Patients With Hepatitis C Virus/Human Immunodeficiency Virus Co-infection

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 4, 2009, Pages

  Shire, Norah J ^a,b   Rao, Marepalli B ^b   Succop, Paul ^b   Buncher, C Ralph ^b   Andersen, Janet A ^c   Butt, Adeel A ^d   Chung, Raymond T ^e   Sherman, Kenneth E ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOPSY; CD4+ T LYMPHOCYTE; CLINICAL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ERROR; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER CIRRHOSIS; LIVER FIBROSIS; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MODEL; NON INVASIVE PROCEDURE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS; VIRUS INFECTION;

EID: 62849109950     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.12.016     Document Type: Article

References (25)

1. Williams A.L., and Hoofnagle J.H. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 95 (1988) 734-739
2. Sheth S.G., Flamm S.L., Gordon F.D., et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 93 (1998) 44-48
3. Poynard T., Bedossa P., and METAVIR and CLINIVIR Cooperative Study Groups. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat 4 (1997) 199-208
4. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
5. Bonacini M., Hadi G., Govindarajan S., et al. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 92 (1997) 1302-1304
6. Sterling R.K., Lissen E., Clumeck N., et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43 (2006) 1317-1325
7. Forns X., Ampurdanes S., Llovet J.M., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
8. Adams L.A., Bulsara M., Rossi E., et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 51 (2005) 1867-1873
9. Kelleher T.B., Mehta S.H., Bhaskar R., et al. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol 43 (2005) 78-84
10. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
11. Lackner C., Struber G., Liegl B., et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 41 (2005) 1376-1382
12. Patel K., Gordon S.C., Jacobson I., et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 41 (2004) 935-942
13. Rossi E., Adams L., Prins A., et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 49 (2003) 450-454
14. McCullagh P. Regression models for ordinal data. J R Stat Soc B (1980) 109-142
15. Dobson A.J. An introduction to generalized linear models. 2nd ed. (2002), Chapman & Hall, New York
16. Poynard T., Imbert-Bismut F., Munteanu M., et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 3 (2004) 8
17. In: Bacon B.R., Goodman Z.D., and Brunt E.M. (Eds). Pathologic evaluation of fibrosis (2003), AASLD, Boston, MA
18. Seeff L.B., and Hoofnagle J.H. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 36 Suppl 1 (2002) S1-S2
19. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
20. Nunes D., Fleming C., Offner G., et al. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease. J Acquir Immune Defic Syndr 40 (2005) 538-544
21. Myers R.P., Benhamou Y., Imbert-Bismut F., et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 17 (2003) 721-725
22. Macias J., Giron-Gonzalez J.A., Gonzalez-Serrano M., et al. Prediction of liver fibrosis in HIV/HCV-coinfected patients by simple noninvasive indexes. Gut 55 (2006) 409-414
23. Kelleher T.B., and Afdhal N. Assessment of liver fibrosis in co-infected patients. J Hepatol 44 Suppl (2006) S126-S131
24. Bedossa P., Poynard T., Naveau S., et al. Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 12 (1988) 173-178
25. Fontana R.J., Kleiner D.E., Bilonick R., et al. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology 44 (2006) 925-935